Showing results (51-60 of 174) with videos related to
Sort By:
Pageof 18
Rapid Communications in Mass Spectrometry : RCM|July 26, 2005
Mass spectrometric investigation of gaseous YbH, YbO and YbOH moleculesS Brutti, T Terai, M Yamawaki, et al.Journal of Inorganic Biochemistry|February 28, 2016
Water-soluble Ru(II)- and Ru(III)-halide-PTA complexes (PTA=1,3,5-triaza-7-phosphaadamantane): Chemical and biological propertiesF Battistin, F Scaletti, G Balducci, et al.Hepato-Gastroenterology|October 1, 1990
Lactitol in the treatment of chronic hepatic encephalopathy--a randomized cross-over comparison with lactuloseO Riggio, G Balducci, F Ariosto, et al.Heart (British Cardiac Society)|June 23, 1999
Anticoagulation in pregnant women with mechanical heart valve prosthesesS S Meschengieser, C G Fondevila, M T Santarelli, et al.Medicina|January 1, 1997
Requirement of a plasma fraction for the loss of large von Willebrand factor multimers induced by high wall shear rateA C Kempfer, C E Farías, M A Schattner, et al.Prostaglandins|August 1, 1980
Ovarian hormones inhibit the release of prostacyclin-like material from isolated rat uterusM F Gimeno, E S Borda, M A Lazzari, et al.Thrombosis Research|October 1, 1989
Effect of acenocoumarine on the breast-fed infantC G Fondevila, S Meschengieser, A Blanco, et al.Thrombosis Research|February 15, 1994
Platelet aggregation inhibition by mononuclear leukocytesM A Schattner, M R Finiasz, J A Notrica, et al.Scandinavian Journal of Immunology|May 1, 1991
Interferon-gamma enhances PAF-acether production by stimulated human polymorphonuclear leucocytesJ R Geffner, M A Schattner, M A Lazzari, et al.Prostaglandins|June 1, 1980
Human platelet rich plasma and human serum protects from inactivation the antiaggregatory capacity of prostacyclin-like material (PGI2) produced by the rat stomach fundusE S Borda, M A Lazzari, M F Gimeno, et al.Pageof 18